136 Folgen

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

GRACEcast Lung Cancer Audio cancerGRACE - H. Jack West, MD

    • Wissenschaft

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

    Squamous Lung Cancer Part 5, Q and A Session (audio)

    Squamous Lung Cancer Part 5, Q and A Session (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, answers audience questions about squamous lung cancer.

    • 13 Min.
    Squamous Lung Cancer, Part 4: Immunotherapy (audio)

    Squamous Lung Cancer, Part 4: Immunotherapy (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, describes current research in immunotherapy as treatment for squamous lung cancer.

    • 7 Min.
    Squamous Lung Cancer, Part 3: Treatment (audio)

    Squamous Lung Cancer, Part 3: Treatment (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, outlines treatment options for squamous lung cancer.

    • 12 Min.
    Squamous Lung Cancer, Part 2: Genomic Testing (audio)

    Squamous Lung Cancer, Part 2: Genomic Testing (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, discusses the importance of genomic testing in squamous lung cancer.

    • 11 Min.
    Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (audio)

    Squamous Lung Cancer, Part 1: Diagnosis, Presentation and Workup (audio)

    Dr. David Spigel, Sarah Cannon Cancer Center, describes the diagnosis, presentation and workup of squamous lung cancer.

    • 15 Min.
    ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

    ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)

    Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint PD-L1 inhibitor MPDL3280A in advanced NSCLC.

    • 5 Min.

Top‑Podcasts in Wissenschaft

Rätsel der Wissenschaft
DER STANDARD
Aha! Zehn Minuten Alltags-Wissen
WELT
radioWissen
Bayerischer Rundfunk
ZEIT WISSEN. Woher weißt Du das?
ZEIT ONLINE
Edition Zukunft
DER STANDARD
Sean Carroll's Mindscape: Science, Society, Philosophy, Culture, Arts, and Ideas
Sean Carroll | Wondery

Mehr von GRACEcast

GRACEcast Cancer 101 Video
cancerGRACE - H. Jack West, MD
GRACEcast Head and Neck Cancer Video NEW
cancerGRACE - H. Jack West, MD
GRACEcast Bladder Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Cancer 101 Audio
cancerGRACE - H. Jack West, MD
GRACEcast Kidney Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Pancreatic Cancer Video
cancerGRACE - H. Jack West, MD